NCT02894034

Brief Summary

Sub Arachnoid Hemorrhage (SAH) is a public health concern because of its high incidence (7/100 000 inhab.), its mortality rate (25%), and its morbidity rate (50%).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 21, 2013

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 9, 2016

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 19, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 19, 2022

Completed
Last Updated

June 12, 2026

Status Verified

June 1, 2026

Enrollment Period

9 years

First QC Date

September 5, 2016

Last Update Submit

June 11, 2026

Conditions

Subarachnoid Hemorrhage

Keywords

optic nerve sheathmeningeal hemorrhageearly phaseprognostic

Outcome Measures

Primary Outcomes (1)

  • patient survival

    patient survival

    month 6

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient admitted to the Neurosurgical Urgent Care Unit for SAH following a ruputred aneurysm

You may qualify if:

  • Patients 18 years or older
  • Patient admitted to the Neurosurgical Urgent Care Unit for SAH following a ruptured aneurysm
  • Patients or one of their loved ones providing written informed consent
  • Patients with healthcare coverage

You may not qualify if:

  • Unavailability of a CTc in the initial phase (within the first 12 hours) or absence of 1-mm slices from the scan
  • Trauma to the optic globe or optic nerve pathology
  • Preexisting anomalies of ICP or history of neurosurgical cerebral pathologies
  • SAH of non aneurysm origin (e.g. arterio-venous malformation (AVM), tumor, trauma, sepsis)
  • Patients under legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens

Amiens, 80054, France

Location

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Patrick JEANJEAN, MD

    CHU Amiens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2016

First Posted

September 9, 2016

Study Start

August 21, 2013

Primary Completion

August 19, 2022

Study Completion

August 19, 2022

Last Updated

June 12, 2026

Record last verified: 2026-06

Locations

FR(1)